---
schema_version: "secwatch.filing_event.v1"
accession: "0000950123-24-003417"
form_type: "8-K"
ticker: "LXEO"
cik: "0001907108"
company_name: "Lexeo Therapeutics, Inc."
filed_at: "2024-04-22T23:59:59+00:00"
generated_at: "2026-06-03T14:31:53.279017+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Bernard Davitian will not stand for reelection at Lexeo's 2024 annual meeting

## Summary
- Bernard Davitian notified Lexeo on April 16, 2024, that he will not seek reelection.
- His departure is effective at the June 25, 2024 annual meeting of stockholders.
- The decision is not due to any disagreement with the company's operations or policies.
- No replacement director has been announced at this time.

## SEC filing metadata
- accession: 0000950123-24-003417
- form_type: 8-K
- ticker: LXEO
- cik: 0001907108
- company_name: Lexeo Therapeutics, Inc.
- filed_at: 2024-04-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1907108/000095012324003417/0000950123-24-003417-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1907108/000095012324003417/lxeo-20240422.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950123-24-003417
- JSON: https://secwatch.observer/filing/0000950123-24-003417.json
- Plain text: https://secwatch.observer/filing/0000950123-24-003417.txt

## Key facts
- Executive change
  Bernard Davitian departed as Director at Lexeo Therapeutics, Inc..
  - Action: not stand for reelection
  - Role: Director
  source text: On April 16, 2024, Bernard Davitian notified Lexeo Therapeutics, Inc. (the “Company”) that he does not intend to stand for reelection at the Company’s 2024 annual meeting of stockholders on June 25, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1907108/000095012324003417/0000950123-24-003417-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.